Verastem Oncology
We are advancing innovation in rare ovarian cancer, including the first FDA-approved treatment for KRAS-mutant recurrent low …
Who We Are | Verastem, Inc.
We’re a team with diverse experiences, perspectives, skills, and backgrounds, unwavering in our pursuit of a singular goal: making …
Verastem, Inc. (VSTM) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and …
Verastem Oncology - Wikipedia
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat …
Verastem Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
1 day ago · VSTM | Complete Verastem Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …
Verastem Oncology - LinkedIn
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and …
VSTM | Verastem Inc. Advanced Charts | MarketWatch
1 day ago · Verastem Inc. advanced stock charts by MarketWatch. View VSTM historial stock data and compare to other stocks and …
Verastem (VSTM) Stock Price & Overview
3 days ago · A detailed overview of Verastem, Inc. (VSTM) stock, including real-time price, chart, key statistics, news, and more.
What is the current Price Target and Forecast for Verastem (VSTM)
4 days ago · Based on short-term price targets offered by eight analysts, the average price target for Verastem comes to $15.00. The …
FDA grants accelerated approval to the combination of avutometinib
On May 8, 2025, the Food and Drug Administration granted accelerated approval to the combination of avutometinib and defactinib …